Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian E Serfling

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancers|November 27, 2021
Radioligands Targeting Fibroblast Activation Protein (FAP)Thomas Lindner, Frederik L Giesel, Clemens Kratochwil, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2020
Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia veraPhilipp E Hartrampf, Bernhard Petritsch, Andreas K Buck, et al.
Current Cardiology Reports|October 13, 2022
Therapeutic Effects of Lipid Lowering Medications on Myocardial Blood Flow, Inflammation, and Sympathetic Nerve Activity Using Nuclear TechniquesTakahiro Higuchi, Sebastian E Serfling, Steven P Rowe, et al.
Nuklearmedizin. Nuclear Medicine|December 22, 2023
Red Bull PET/CTSebastian E Serfling, Andreas Buck, Steven P Rowe, et al.
Seminars in Nuclear Medicine|March 22, 2024
FAPI-PET in Cardiovascular DiseaseTakahiro Higuchi, Sebastian E Serfling, David M Leistner, et al.
Seminars in Nuclear Medicine|June 25, 2023
PSMA PET/CT for Response Assessment of <sup>177</sup>Lu-PSMA TherapyPhilipp E Hartrampf, Sebastian E Serfling, Kerstin Michalski, et al.
Radiologie (Heidelberg, Germany)|May 22, 2024
[Clinical significance of neuroendocrine tumors : Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management]Philipp E Hartrampf, Sebastian E Serfling, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|February 2, 2023
Complete Remission Upon Peptide Receptor Radionuclide Therapy in a G2 Pancreatic Neuroendocrine TumorAlexander Weich, Sebastian E Serfling, Heqing Yi, et al.
Clinical Nuclear Medicine|February 23, 2024
Monitoring Dual-Cancer Treatment in a Patient With Prostate and Hepatocellular Carcinoma Using Prostate-Specific Membrane Antigen-Directed PET/CTFlorian P Reiter, Alexander Weich, Takahiro Higuchi, et al.
Endocrine|June 25, 2022
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinomaSebastian E Serfling, Yingjun Zhi, Felix Megerle, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancers|November 27, 2021
Radioligands Targeting Fibroblast Activation Protein (FAP)Thomas Lindner, Frederik L Giesel, Clemens Kratochwil, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2020
Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia veraPhilipp E Hartrampf, Bernhard Petritsch, Andreas K Buck, et al.
Current Cardiology Reports|October 13, 2022
Therapeutic Effects of Lipid Lowering Medications on Myocardial Blood Flow, Inflammation, and Sympathetic Nerve Activity Using Nuclear TechniquesTakahiro Higuchi, Sebastian E Serfling, Steven P Rowe, et al.
Nuklearmedizin. Nuclear Medicine|December 22, 2023
Red Bull PET/CTSebastian E Serfling, Andreas Buck, Steven P Rowe, et al.
Seminars in Nuclear Medicine|March 22, 2024
FAPI-PET in Cardiovascular DiseaseTakahiro Higuchi, Sebastian E Serfling, David M Leistner, et al.
Seminars in Nuclear Medicine|June 25, 2023
PSMA PET/CT for Response Assessment of <sup>177</sup>Lu-PSMA TherapyPhilipp E Hartrampf, Sebastian E Serfling, Kerstin Michalski, et al.
Radiologie (Heidelberg, Germany)|May 22, 2024
[Clinical significance of neuroendocrine tumors : Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management]Philipp E Hartrampf, Sebastian E Serfling, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|February 2, 2023
Complete Remission Upon Peptide Receptor Radionuclide Therapy in a G2 Pancreatic Neuroendocrine TumorAlexander Weich, Sebastian E Serfling, Heqing Yi, et al.
Clinical Nuclear Medicine|February 23, 2024
Monitoring Dual-Cancer Treatment in a Patient With Prostate and Hepatocellular Carcinoma Using Prostate-Specific Membrane Antigen-Directed PET/CTFlorian P Reiter, Alexander Weich, Takahiro Higuchi, et al.
Endocrine|June 25, 2022
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinomaSebastian E Serfling, Yingjun Zhi, Felix Megerle, et al.
Pageof 8